Praxis Precision Medicines, Inc. PRAX
280.78
(1.01)
(0.36%)
as of 25 Sep
- Market cap
- $7.9B
- P/E
- 0.0×
Follow PRAX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
15.46 | 15.66 | 10.03 | 5.05 | |
Current Ratio |
15.73 | 15.88 | 10.22 | 5.18 | |
Net Debt/EBITDA |
7.78 | 7.39 | 6.14 | 3.38 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.93 | 0.93 | 0.86 | 0.88 | |
Capex/Depreciation |
1.55 | 0.10 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.66) | (2.98) | (3.39) | (2.96) | |
Capex per Share |
(0.03) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(2.70) | (2.98) | (3.39) | (2.96) | |
Cash per Share |
26.04 | 27.24 | 26.63 | 12.16 | |
Shareholders Equity per Share |
46.03 | 48.81 | 39.02 | 15.63 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
46.03 | 48.81 | 39.02 | 15.63 | |
Free Cash Flow |
(78.56) | (86.21) | (76.32) | (65.06) | |
Working Capital |
722.85 | 747.53 | 551.14 | 220.96 | |
Capital Expenditures |
(1.02) | (0.06) | 0.00 | 0.00 | |
Net Current Asset Value |
722.85 | 747.53 | 551.14 | 220.96 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
26.11 | 27.03 | 18.58 | 22.91 | |
Average Assets |
921.47 | 969.47 | 710.51 | 406.32 | |
Average Common Equity |
872.63 | 924.59 | 661.79 | 363.09 |
Columns are period end dates